日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erythropoietin receptor on cDC1s dictates immune tolerance.

cDC1s上的促红细胞生成素受体决定免疫耐受性。

Zhang Xiangyue, McGinnis Christopher S, Yu Guotao, Chen Sijie, Zheng Pingping, Schürch Christian M, Hiam-Galvez Kamir J, Reticker-Flynn Nathan E, Guo Wenhui, Yao Winnie, Qiu Jingtao, Muselman Alexander, Linde Ian L, Hickey John W, Yan Hao, Tran Victoria M, Qiu Wenli, Brichart-Vernos Delphine, Hirai Toshihito, Yu Bo, An Xiuli, Xiao Yanling, Paidassi Helena, Scharschmidt Tiffany C, Angelo Michael, Sheppard Dean, Chi Hongbo, Satpathy Ansuman T, Way Sing Sing, Malissen Bernard, Strober Samuel, Engleman Edgar G

Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity.

肿瘤来源的促红细胞生成素在癌症免疫中起着免疫抑制开关的作用

Chiu David Kung-Chun, Zhang Xiangyue, Cheng Bowie Yik-Ling, Liu Qiang, Hayashi Kazukuni, Yu Bo, Lee Ryan, Zhang Catherine, An Xiuli, Rajadas Jayakumar, Reticker-Flynn Nathan E, Rankin Erinn B, Engleman Edgar G

Spontaneous and experimental models of lymph node metastasis

淋巴结转移的自发性和实验性模型

Breuer, Cort B; Xiong, Zhewen; Wang, Alice; Rodriguez, Grayson E; Abhiraman, Gita C; Garcia, K Christopher; Reticker-Flynn, Nathan E

Lymph nodes: at the intersection of cancer treatment and progression

淋巴结:癌症治疗与进展的交汇点

Reticker-Flynn, Nathan E; Engleman, Edgar G

Skip metastasis in mediastinal lymph node is a favorable prognostic factor in N2 lung cancer patients: a meta-analysis

纵隔淋巴结跳跃性转移是N2期肺癌患者的有利预后因素:一项荟萃分析

Wang, Zihuai; Cheng, Jiahan; Huang, Wenyu; Cheng, Diou; Liu, Yilin; Pu, Qiang; Reticker-Flynn, Nathan E; Liu, Lunxu

Cancer systems immunology

癌症系统免疫学

Reticker-Flynn, Nathan E; Engleman, Edgar G